Literature DB >> 2278998

Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells.

A Kawasaki1, Y Shinkai, Y Kuwana, A Furuya, Y Iigo, N Hanai, S Itoh, H Yagita, K Okumura.   

Abstract

Perforin is one of the important cytolytic factors in cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. In this paper, we report rat mAbs against mouse perforin established by immunization with a recombinant mouse perforin fragment. These mAbs reacted with purified mouse perforin prepared from cytoplasmic granules of an NK-like cell line in ELISA and Western blot analysis. However, none of these mAbs blocked the hemolytic activity of mouse perforin or absorbed it when fixed in the solid phase. These results indicate that all of these mAbs react with denatured but not with native mouse perforin. By using a combination of the mAbs, we established a sandwich ELISA, for quantitating the cellular contents of perforin. These mAbs were also useful for immunohistochemical staining analysis, and perforin was detected in the cytoplasmic granules of CTL and NK cell lines. Perforin was also detected in a minor population of lymphocytes of the spleen, liver, and lymph node. In normal spleen cells of 5- to 8-week-old mice, 12-15% of asialo GM1+ cells and 7-21% of CD8+ T cells were perforin-positive, but CD4+ T cells, B cells, and macrophages were totally negative. These data clearly show that perforin is expressed in cells of a cytotoxic character in normal mice, in the same way as in primed mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2278998     DOI: 10.1093/intimm/2.7.677

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  24 in total

1.  Cytotoxic T lymphocyte perforin and Fas ligand working in concert even when Fas ligand lytic action is still not detectable.

Authors:  David Hassin; Orit G Garber; Avihai Meiraz; Yael S Schiffenbauer; Gideon Berke
Journal:  Immunology       Date:  2011-03-29       Impact factor: 7.397

2.  Atrio-His (James) accessory pathway and infiltration of γδ T cells in the heart with MELAS.

Authors:  Gen Matsuzaki; Akifumi Kushiyama; Kenta Uto; Morio Shoda; Yoshinori Seko
Journal:  BMJ Case Rep       Date:  2011-02-02

3.  Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis.

Authors:  Kimberly A Risma; Robert W Frayer; Alexandra H Filipovich; Janos Sumegi
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

4.  Killing of cells by perforin. Resistance to killing is not due to diminished binding of perforin to the cell membrane.

Authors:  J Jones; B P Morgan
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

5.  Inactivation and proteolytic degradation of perforin within lytic granules upon neutralization of acidic pH.

Authors:  T Kataoka; K Togashi; H Takayama; K Takaku; K Nagai
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

6.  Eradication of metastatic tumour cells from lymph nodes by local administration of anti-CD3 antibody.

Authors:  Y Dohi; S Sunada; M Aoki; A Moriguchi; M Okabayashi; M Miyata; H Matsuda
Journal:  Cancer Immunol Immunother       Date:  1993-06       Impact factor: 6.968

7.  Perforin mRNA expression in the inflamed tissues of NZB/W F1 lupus mice decreases with methylprednisolone treatment.

Authors:  T Nakamura; I Ebihara; Y Tomino; K Okumura; H Koide
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

8.  Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.

Authors:  G Berke; D Rosen; D Ronen
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

9.  Characterization of a novel monoclonal antibody against human perforin using transfected cell lines.

Authors:  B C Schlesinger; L Cheng
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

10.  Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody.

Authors:  A Hameed; K J Olsen; L Cheng; W M Fox; R H Hruban; E R Podack
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.